Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Thyroid : Official Journal of the American Thyroid Association|January 20, 2022
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical TrialVatche Tchekmedyian, Lara Dunn, Eric Sherman, et al.
The Journal of Experimental Medicine|February 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAsGnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Nature Biomedical Engineering|March 14, 2020
Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancersSusanne Kossatz, Giacomo Pirovano, Paula Demétrio De Souza França, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
Advances in Therapy|June 4, 2020
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative ReviewAndrés Coca-Pelaz, Jatin P Shah, Juan C Hernandez-Prera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.
Pageof 14